N-803
ImmunityBio
['nmibc', 'mibc', 'pivotal']
final clinical results of pivotal trial of n-803 with bcg in bcg-unresponsive cis and papillary nmibc. reinforcing the role of intravesical therapy in these patients. #asco22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid